FXAIX | SPFFX | FXAIX / SPFFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 3 years | - |
Gain YTD | 20.776 | 18.979 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 585B | 12.9M | 4,534,884% |
Annual Yield % from dividends | 1.31 | 1.21 | 109% |
Returns for 1 year | 33.63 | 33.48 | 100% |
Returns for 3 years | 37.19 | N/A | - |
Returns for 5 years | 104.21 | N/A | - |
Returns for 10 years | 212.82 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NOIEX | 17.15 | N/A | N/A |
Northern Income Equity | |||
FBTAX | 34.26 | -0.05 | -0.15% |
Fidelity Advisor Biotechnology A | |||
PSPJX | 27.68 | -0.06 | -0.22% |
Principal Large Cap S&P 500 Index J | |||
LAFLX | 13.17 | -0.04 | -0.30% |
Lord Abbett Focused Large Cap Value A | |||
AGGDX | 13.24 | -0.05 | -0.38% |
American Century Focused Global Gr R6 |